CARsgen Therapeutics Holdings Ltd
HKEX:2171

Watchlist Manager
CARsgen Therapeutics Holdings Ltd Logo
CARsgen Therapeutics Holdings Ltd
HKEX:2171
Watchlist
Price: 12.7 HKD -0.94% Market Closed
Market Cap: 7.3B HKD

P/E
Price to Earnings

-8.6
Current
-5.6
Median
22
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-8.6
=
Market Cap
7.3B HKD
/
Net Income
-798.1m CNY
Earnings Growth PEG
CN
CARsgen Therapeutics Holdings Ltd
HKEX:2171
Average P/E: 78.4
Negative Multiple: -8.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -166 388.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
73.6
87%
0.8
US
Amgen Inc
NASDAQ:AMGN
38.8
44%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
273.9
187%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -239.7 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -513.5 N/A N/A
AU
CSL Ltd
ASX:CSL
27.2
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.9
12%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.4 N/A N/A
NL
argenx SE
XBRU:ARGX
42.9
26%
1.7

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-11.5
2-Years Forward
P/E
-12.5
3-Years Forward
P/E
-20